FDA grants RMAT status for Voyager's VY-AADC gene therapy for Parkinson's [Seeking Alpha]
Voyager Therapeutics, Inc. (VYGR)
Last voyager therapeutics, inc. earnings: 3/3 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.voyagertherapeutics.com
Company Research
Source: Seeking Alpha
The FDA grants Regenerative Medicine Advanced Therapy (RMAT) status for Voyager Therapeutics' (NASDAQ: VYGR ) VY-AADC gene therapy for the treatment of Parkinson's disease patients with uncontrolled motor fluctuations. RMAT status provides for the accelerated review of the marketing application and more intensive guidance from the FDA on development. In other words, it includes the benefits of Fast Track and Breakthrough Therapy designations that are granted for drugs. Click to subscribe to real-time analytics on VYGR Now read: Incyte's Jakafi successful in mid-stage study in severe form of GvHD »
Show less
Read more
Impact Snapshot
Event Time:
VYGR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VYGR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VYGR alerts
High impacting Voyager Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VYGR
News
- Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual MeetingGlobeNewswire
- Voyager Therapeutics' (NASDAQ:VYGR) three-year earnings growth trails the splendid shareholder returns [Yahoo! Finance]Yahoo! Finance
- Voyager Therapeutics Announces First Quarter 2024 Conference Call and WebcastGlobeNewswire
- Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting [Yahoo! Finance]Yahoo! Finance
VYGR
Earnings
- 2/28/24 - Beat
VYGR
Sec Filings
- 4/25/24 - Form ARS
- 4/25/24 - Form DEFA14A
- 4/25/24 - Form DEF
- VYGR's page on the SEC website